Market Sentiment Around Loss-Making Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) [Yahoo! Finance]
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) had its "hold" rating re-affirmed by analysts at D. Boral Capital.
Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval [Yahoo! Finance]
Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval
Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split [Yahoo! Finance]